Palbociclib in Combination With Fulvestrant Versus Fulvestrant in Advanced Breast Cancer: A Real-world Study in China
Clinical trial NCT04526028 · UNKNOWN
Trial details
- NCT number
- NCT04526028
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2019-09-13
- Primary completion
- 2023-02-28
- Enrollment
- 612
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.